Chapter PDF
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Aharony D, Krell RD (1991) Pharmacology of peptide leukotriene receptor antanonists. Ann NY Acad Sci 629:125–132
Akerboom TPM, Narayanaswami V, Kunst M, Sies H (1991) ATP-dependent S-(2,4-dinitrophenyl)glutathione transport in canalicular plasma membrane vesicles from rat liver. J Biol Chem 266:13147–13152
Appelgren LE, Hammarström S (1982) Distribution and metabolism of [3H]-labeled leukotriene C3 in the mouse. J Biol Chem 257:531–535
Augstein J, Farmer JB, Lee TB, Sheard P, Tattersall ML (1973) Selective inhibition of slow reacting substance of anaphylaxis. Nature New Biol 245:214–216
Ball HA, Keppler D (1987) ω-oxidation products of leukotriene E4 in bile and urine of the monkey. Biochem Biophys Res Commun 148:664–670
Baumert T, Huber M, Mayer D, Keppler D (1989) Ethanol-induced inhibition of leukotriene degradation by ω-oxidation. Eur J Biochem 182:223–229
Bell RL, Young PR, Albert D, Lanni C, Summers JB, Brooks DW, Rubin P, Carter GW (1992) The discovery and development of zileuton — an orally active 5-lipoxygenase inhibitor. Int J Immunopharmacol 14:505–510
Bernström K, Kammarström S (1981) Metabolism of leukotriene D by porcine kidney. J Biol Chem 256:9579–9582
Bernström K, Kammarström S (1986) Metabolism of leukotriene E4 by rat tissues: formation of N-acetyl leukotriene E4. Arch Biochem Biophys 244:486–491
Board P, Nishida T, Gatmaitan Z, Che M, Arias IM (1992) Erythrocyte membrane transport of glutathione conjugates and oxidized glutathione in the Dubin-Johnson syndrome and in rats with hereditary hyperbilirubinemia. Hepatology 15:722–725
Borgeat P, Picard S, Vallerand P, Bourgoin S, Odeimat A, Sirois P, Poubelle PE (1990) Automated on-line extraction and profiling of lipoxygenase products of arachidonic acid by high-performance liquid chromatography. Meth Enzymol 187:98–116
Christie PE, Tagari P, Ford-Hutchinson AW, Charleson S, Chee P, Arm JP, Lee TH (1991) Urinary leukotriene-E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Resp Dis 143:1025–1029
Dahinden CA, Wirthmueller U (1990) Release and metabolism of leukotriene A4 in neutrophil-mast cell interactions. Methods Enzymol 187:567–577
Dahinden CA, Clancy RM, Gross M, Chiller JM, Hugli TE (1985) Leukotriene C4 production by murine mast cells: evidence of a role for extracellular leukotriene A4. Proc Natl Acad Sci USA 82:6632–6636
Dahlén SE, Björck T, Hedqvist P, Arfors KE, Hammarström S, Lindgren JÅ, Samuelsson B (1981) Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 80:3887–3891
Denzlinger C, Rapp S, Hagmann W, Keppler D (1985) Leukotrienes as mediators in tissue trauma. Science 230:330–332
Denzlinger C, Guhlmann A, Scheuber PJ, Wilker D, Hammer DK, Keppler D (1986) Metabolism and analysis of cysteinyl leukotrienes in the monkey. J Biol Chem 261:15601–15606
Denzlinger C, Kapp A, Grimberg M, Gerhartz HH, Wilmanns W (1990) Enhanced endogenous leukotriene biosynthesis in patients treated with granulocyte-macrophage colony-stimulating factor. Blood 76:1765–1770
Dixon RAF, Jones RE, Diehl RE, Bennett CD, Kargman S, Rouzer CA (1988) Cloning of the cDNA for human 5-lipoxygenase. Proc Natl Acad Sci USA 85:416–420
Dixon RAF, Diehl RE, Opas E, Rands E, Vickers PJ, Evans JF, Gillard JW, Miller DK (1990) Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 343:282–284
Drazen JM, Austen KF (1987) Leukotrienes and airway responses. Am Rev Respir Dis 136:985–998
Evans JF, Léveillé C, Mancini JA, Prasit P, Thérien M, Zamboni R, Gauthier JY, Fortin R, Charleson P, MacIntyre DE, Luell S, Bach TJ, Meurer R, Guay J, Vickers PJ, Rouzer CA, Gillard JW, Miller DK (1991) 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors. Molec Pharmacol 40:22–27
Falk E, Müller M, Huber M, Keppler D, Kurz G (1989) Direct photoaffinity labeling of leukotriene binding sites. Eur J Biochem 186:741–747
Fauler J, Tsikas D, Holch M, Seekamp A, Nerlich ML, Sturm J, Frölich JC (1991) Enhanced urinary excretion of leukotriene E4 by patients with multiple trauma with or without adult respiratory distress syndrome. Clin Sci 80:497–504
Feinmark SJ (1990) Leukotriene C4 biosynthesis during polymorphonuclear leukocytevascular cell interactions. Methods Enzymol 187:559–567
Ferber E, Resch K (1973) Phospholipid metabolism of stimulated lymphocytes: activation of acyl-CoA: lysolecithin acyltransferases in microsomal membranes. Biochim Biophys Acta 296:335–349
Feuerstein G (1985) Autonomic pharmacology of leukotrienes. J Auton Pharmac 5:149–168
Fitzsimmons BJ, Rockach J (1989) Enzyme inhibitors and leukotriene receptor antagonists. In: Rockach J (ed) Leukotrienes and lipoxygenases. Chemical, biological and clinical aspects. Elsevier, Amsterdam, pp 427–502
Ford-Hutchinson AW (1990) Leukotriene B4 in inflammation. Crit Rev Immunol 10:1–12
Ford-Hutchinson AW (1991a) FLAP: a novel drug target for inhibiting the synthesis of leukotrienes. TIPS 121:68–70
Ford-Hutchinson AW (1991b) Leukotrienes and chemotaxis — 5-lipoxygenase activation and control. In: Sies H, Flohé L, Zimmer G (eds) Molecular aspects of inflammation. Springer, Berlin Heidelberg New York, pp 33–39
Foster A, Letts G, Charleson S, Fitzsimmons B, Blacklock B, Rokach J (1988) The in vivo production of peptide leukotrienes after pulmonary anaphylaxis in the rat. J Immunol 141:3544–3550
Foxwell BM, Mackie A, Ling V, Ryffel B (1989) Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein. Mol Pharmacol 36:543–546
Gillard J, Ford-Hutchinson AW, Chan C, Charleson S, Denis D, Foster A, Fortin R, Leger S, McFarlane CS, Morton H, Piechuta H, Riendeau D, Rouzer CA, Rokach J, Young R, MacIntyre DE, Peterson L, Bach T, Eiermann G, Hopple S, Humes J, Hupe L, Luell S, Metzger J, Meurer R, Miller DK, Opas E, Pacholok S (1989) L-663,536 (MK-886) (3-[1-(4-chlorbenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol 67:456–464
Guhlmann A, Keppler A, Kästner S, Krieter H, Brückner UB, Messmer K, Keppler D (1989) Prevention of endogenous leukotriene production during anaphylaxis in the guinea pig by an inhibitor of leukotriene biosynthesis (MK-886) but not by dexamethasone. J Exp Med 170:1905–1918
Habenicht AJR, Goerig M, Rothe DER, Specht E, Ziegler R, Glomset JA, Graf T (1989) Early reversible induction of leukotriene synthesis in chicken myelomonocytic cells transformed by a temperature sensitive mutant of avian leukemia virus E26. Proc Natl Acad Sci USA 86:921–924
Hackshaw KV, Voelkel NF, Thomas RB, Westcott JY (1992) Urine leukotriene E4 levels are elevated in patients with active systemic lupus erythematosus. J Rheumatol 19:252–258
Haeggström JR, Wetterholm A, Vallee BL, Samuelsson B (1990) Leukotriene A4 hydrolase: an epoxide hydrolase with peptidase activity. Biochem Biophys Res Commun 173:431–437
Hagmann W, Korte M (1990) Hepatic uptake and metabolic disposition of leukotriene B4 in rats. Biochem J 267:467–470
Hagmann W, Denzlinger C, Keppler D (1984) Role of peptide leukotrienes and their hepatobiliary elimination in endotoxin action. Circ Shock 14:223–235
Hagmann W, Denzlinger C, Keppler D (1985) Production of peptide leukotrienes in endotoxin shock, FEBS Lett 180:309–313
Hagmann W, Denzlinger C, Rapp S, Weckbecker G, Keppler D (1986) Identification of the major endogenous leukotriene metabolite in the bile of rats as N-acetyl leukotriene E4. Prostaglandins 31:239–251
Hagmann W, Steffan A-M, Kirn A, Keppler D (1987) Leukotrienes as mediators in frog virus 3-induced hepatitis in rats. Hepatology 7:732–736
Hagmann W, Parthé S, Kaiser I (1989) Uptake, production and metabolism of cysteinyl leukotrienes in the isolated perfused rat liver. Inhibition of leukotriene uptake by cyclosporine. Biochem J 261:611–616
Hagmann W, Kaiser I, Jakschik BA (1991) The sensitized liver represents a rich source of endogenous leukotrienes. Hepatology 13:482–488
Hammarström S (1983) Leukotrienes. Ann Rev Biochem 52:355–377
Hammarström S, Örning L, Bernström K (1985) Metabolism of leukotrienes. Mol Cell Biochem 69:7–16
Hansson G, Lindgren J.-Å, Dahlén SE, Hedqvist P, Samuelsson B (1981) Identification and biological activity of novel omega-oxidized metabolites of leukotriene B4 from human leukocytes. FEBS Lett 130:107–112
Harper TW, Garrity MJ, Murphy RC (1986) Metabolism of leukotriene B4 in isolated rat hepatocytes. Identification of a novel 18-carboxy-19,20-dinor leukotriene B4 metabolite. J Biol Chem 261:5414–5418
Heavey DJ, Soberman RJ, Lewis RA, Spur B, Austen KF (1987) Critical considerations in the development of an assay for sulfidopeptide leukotrienes in plasma. Prostaglandins 33:693–708
Henderson WR, Jörg A, Klebanoff SJ (1982) Eosinophil peroxidase-mediated inactivation of leukotrienes B4 C4 and D4. J Immunol 128:2609–2613
Herron DK, Goodson T, Bollinger NG, Swansonbean D, Wright IG, Staten GS, Thompson AR, Froelich LL, Jackson WT (1992) Leukotriene-B4 receptor antagonists — the LY255283-series of hydroxyacetophenones. J Med Chem 35:1818–1828
Huber M, Keppler D (1987) Inhibition of leukotriene D4 catabolism by D-penicillamine. Eur J Biochem 167:73–79
Huber M, Keppler D (1988) Leukotrienes and the mercapturate pathway. In: Sies H, Ketterer B (eds) Glutathione conjugation. Mechanisms and biological significance. Academic, London, pp 449–470
Huber M, Keppler D (1990) Eicosanoids an the liver. In: Popper H, Schaffner F (eds) Progress in liver diseases, vol 9. Saunders, Philadelphia, pp 117–141
Huber M, Guhlmann A, Jansen PLM, Keppler D (1987) Hereditary defect of hepatobiliary cysteinyl leukotriene elimination in mutant rats with defective hepatic anion excretion. Hepatology 7:224–228
Huber M, Beutler B, Keppler D (1988) Tumor necrosis factor α stimulates leukotriene production in vivo. Eur J Immunol 18:2085–2088
Huber M, Kästner S, Schölmerich J, Gerok W, Keppler D (1989) Cysteinyl leukotriene analysis in human urine: enhanced excretion in patients with liver cirrhosis and hepatorenal syndrome. Eur J Clin Invest 19:53–60
Huber M, Müller J, Leier I, Jedlitschky G, Ball HA, Moore KP, Taylor GW, Williams R, Keppler D (1990) Metabolism of cysteinyl leukotrienes in monkey and man. Eur J Biochem 194:309–315
Hughey RP, Rankin BB, Elce JS, Curthoys NP (1978) Specificity of a particulate rat renal peptidase and its localization along with other enzymes of mercapturic acid synthesis. Arch Biochem Biophys 186:211–217
Irvine RF (1982) How is the level of free arachidonic acid controlled in mammalian cells? Biochem J 204:3–16
Ishikawa T, Kobayashi K, Sogame Y, Hayashi K (1989) Evidence for leukotriene C4 transport mediated by an ATP-dependent glutathione S-conjugate carrier in rat heart and liver plasma membranes. FEBS Lett 259:95–98
Ishikawa T, Müller M, Klünemann C, Schaub T, Keppler T (1990) ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. J Biol Chem 265:19279–19286
Jansen PLM, Peters WH, Lamers WH (1985) Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology 5:573–579
Jedlitschky G, Leier I, Huber M, Mayer D, Keppler D (1990) Inhibition of leukotriene ω-oxidation by ω-trifluoro analogs of leukotrienes. Arch Biochem Biophys 282:333–339
Jedlitschky G, Huber M, Völkl A, Müller M, Leier I, Müller J, Lehmann W-D, Fahimi HD, Keppler D (1991) Peroxisomal degradation of leukotrienes by β-oxidation from the ω-end. J Biol Chem 266:24763–24772
Jones DA, Fitzpatrick FA (1990) Leukotriene B4 biosynthesis by erythrocyte-neutrophil interactions. Methods Enzymol 187:553–559
Jones TR, Zamboni R, Belley M, Champion E, Charette L, Ford-Hutchinson AW, Gauthier J-Y, Leger S, Lord A, Masson P, McFarlane CS, Metters KM, Pickett C, Piechuta H, Young RN (1991) Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571. Can J Physiol Pharmacol 69:1847–1854
Keppler A, Örning L, Bernström K, Hammarström S (1987) Endogenous leukotriene D4 formation during anaphylactic shock in the guinea pig. Proc Natl Acad Sci USA 84:5903–5907
Keppler D (1988) Stoffwechsel und Analyse von Leukotrienen in Vivo. Klin Wochenschr. 66:997–1004
Keppler D, Hagmann W, Rapp S, Denzlinger C, Koch HK (1985) The relation of leukotrienes to liver injury. Hepatology 5:883–891
Keppler D, Hagmann W, Rapp S (1987) Role of leukotrienes in endotoxin action in vivo. Rev Infect Diseases 9:580–584
Keppler D, Huber M, Hagmann W, Ball HA, Guhlmann A, Kästner S (1988) Metabolism and analysis of endogenous cysteinyl leukotrienes. Ann NY Acad Sciences 524:68–74
Keppler D, Huber M, Baumert T, Guhlmann A (1989) Metabolic inactivation of leukotrienes. Adv Enzyme Regul 28:307–319
Keppler D, Guhlmann A, Oberdorfer F, Krauss K, Müller J, Ostertag H, Huber M (1991) Generation and metabolism of cysteinyl leukotrienes in vivo. Ann NY Acad Sciences 629:100–104
Keppler D, Müller M, Klünemann C, Guhlmann A, Krauss K, Müller J, Berger U, Leier I, Mayatepek E (1992) Transport and in vivo elimination of cysteinyl leukotrienes. Adv Enzyme Regul 32:107–116
Kitamura T, Alroy J, Gatmaitan Z, Inoue M, Mikami T, Jansen P, Arias IM (1992) Defective biliary excretion of epinephrine metabolites in mutant (TR−) rats: relation to the pathogenesis of black liver in the Dubin-Johnson syndrome and Corriedale sheep with an analogous excretory defect. Hepatology 15:1154–1159
Kobayashi K, Sogame Y, Hayashi K, Nicotera P, Orrenius S (1988) ATP stimulates the uptake of S-dinitrophenylglutathione by rat liver plasma membrane vesicles. FEBS Lett 240:55–58
Kobayashi K, Sogame Y, Hara H, Hayashi K (1990) Mechanism of glutathione S-conjugate transport in canalicular and basolateral rat liver plasma membranes. J Biol Chem 265:7737–7741
Kondo T, Dale GL, Beutler E (1980) Glutathione transport by inside-out vesicles from human erythrocytes. Proc Natl Acad Sci USA 77:6359–6362
Kozak EM, Tate SS (1982) Glutathione-degrading enzymes of microvillus membranes. J Biol Chem 257:6322–6327
Kurz G, Müller M, Schramm U, Gerok W (1989) Identification and function of bile salt binding polypeptides of hepatocyte membrane. In: Petzinger E, Kinne RK-H, Sies H (eds) Hepatic transport of organic substances. Springer, Berlin Heidelberg New York, pp 267–278
Lam BK, Owen WF Jr, Austen KF, Soberman RJ (1989) The identification of a distinct export step following the biosynthesis of leukotriene C4 by human eosinophils. J Biol Chem 264:12885–12889
Lam BK, Gagnon L, Austen KF, Soberman RJ (1990) The mechanism of leukotriene B4 export from human polymorphonuclear leukocytes. J Biol Chem 265:13438–13441
Lee CW, Lewis RA, Tauber AI, Mehrotra M, Corey EJ, Austen KF (1983) The myeloperoxidase-dependent metabolism of leukotrienes C4 D4 and E4 to 6-trans-leukotriene B4 diastereoisomers and the subclass-specific S-diastereoisomeric sulfoxides. J Biol Chem 258:15004–15010
Lehr HA, Guhlmann A, Nolte D, Keppler D, Messmer K (1991) Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster. J Clin Invest 87:2036–2041
Leier I, Müller M. Jedlitschky G, Keppler D (1992) Leukotriene uptake by hepatocytes and hepatoma cells. Eur J Biochem 209: in press
Lewis MA, Krell RD, Jones TR (1991) Third-generation peptidoleukotriene receptor antagonists. In: Crooke ST, Wong A (eds) Lipoxygenases and their products. Academic, San Diego, pp 207–234
Lewis RA, Austen KF (1984) The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology. J Clin Invest 73:889–897
Lewis RA, Drazen JM, Austen KF, Toda M, Brion F, Marfat A, Corey EJ (1981) Contractile activities of structural anlogs of leukotrienes C and D: role of the polar substituents. Proc Natl Acad Sci USA 78:4579–4583
Lewis RA, Austen KF, Soberman RJ (1990) Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. New Engl J Med 323:645–655
Lin L-L, Lin AY, Knopf JL (1992) Cytosolic phospholipase A2 is coupled to hormonally regulated release of arachidonic acid. Proc Natl Acad Sci USA 89:6147–6151
Maltby NH, Taylor GW, Ritter JM, Moore K, Fuller RW, Dollery CT (1990) Leukotriene C4 elimination and metabolism in man. J Allergy Clin Immunol 85:3–9
Mathews R (1990) Quantitative gas chromatography-mass spectrometry analysis of leukotriene B4. Meth Enzymol 187:76–81
Matsumoto T, Funk CD, Radmak O, Höög JO, Jörnvall H, Samuelsson B (1988) Molecular cloning and amino acid sequence of human 5-lipoxygenase. Proc Natl Acad Sci USA 85:26–30
Mayatepek E, Lehmann W-D, Fauler J, Tsikas D, Frölich JC, Schutgens RBH, Wanders RJA, Keppler D (1992) Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders. J Clin Invest, in press
McGee JE, Fitzpatrick F (1985) Enzymatic hydration of leukotriene A4: purification and characterization of a novel epoxide hydrolase from human erythrocytes. J Biol Chem 260:12832–12837
McGee JE, Fitzpatrick FA (1986) Erythrocyte-neutrophil interactions: formation of leukotriene B4 by transcellular biosynthesis. Proc Natl Acad Sci USA 83:1349–1353
Miller DK, Gillard JW, Vickers PJ, Sadowski S, Léveillé C, Mancini JA, Charleson P, Dixon RAF, Ford-Hutchinson AW, Fortin R, Gauthier JY, Rodkey J, Rosen R, Rouzer CA, Sigal IS, Strader CD, Evans JF (1990) Identification and isolation of a membrane protein necessary for leukotriene production. Nature 343:278–281
Minami M, Ohishi N, Mutoh H, Izumi T, Bito H, Wada H, Seyama Y, Toh H, Shimizu T (1990) Leukotriene A4 hydrolase is a zinc-containing aminopeptidase. Biochem Biophys Res Commun 173:620–626
Moore KP, Taylor GW, Maltby NH, Siegers D, Fuller RW, Dollery CT, Williams R (1990) Increased production of cysteinyl leukotrienes in hepatorenal syndrome. J Hepatol 11:263–271
Müller M, Ishikawa T, Berger U, Lucka L, Klünemann C, Schreyer A, Kannicht C, Reutter W, Kurz G, Keppler D (1991a) ATP-dependent transport of taurocholate across the hepatocyte canalicular membrane mediated by a 110 kDa glycoprotein binding ATP and bile salt. J Biol Chem 266:18920–18926
Müller M, Falk E, Sandbrink R, Berger U, Leier I, Jedlitschky G, Huber M, Kurz G, Keppler D (1991b) Photoaffinity labeling of leukotriene binding sites in hepatocytes and hepatoma cells. Advan Prostaglandin, Thromboxane, Leukotriene Res 21A:395–398
Murphy RC (1984) Mass spectrometric quantitation and analysis of leukotrienes and other 5-lipoxygenase metabolites. Prostaglandins 28:597–601
Murphy RC, Sala A (1990) Quantitation of sulfidopeptide leukotrienes in biological fluids by gas chromatography-mass spectrometry. Meth Enzymol 187:90–98
Murphy RC, Hammarström S, Samuelsson B (1979) Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci USA 76:4275–4279
Nicoll-Griffith D, Zamboni R (1990) BIO-fully automated sample treatment high-performance liquid chromatography and radioimmunoassay for leukotriene E4 in human urine from asthmatics. J Chromatography 526:341–354
Odlander B, Jakobsson PJ, Rosén A, Claesson H-E (1988) Human B and T lymphocytes convert leukotriene A4 into leukotriene B4. Biochem Biophys Res Commun 153:203–208
Örning L (1987) ω-Oxidation of cysteine-containing leukotrienes by rat liver microsomes. Isolation and characterization of ω-hydroxy and ω-carboxy metabolites of leukotriene E4 and N-acetyl-leukotriene E4. Eur J Biochem 170:77–85
Örning L, Kaijser RL, Hammarström S (1985) In vivo metabolism of leukotriene C4 in man: Urinary excretion of leukotriene E4. Biochem Biophys Res Commun 130:214–220
Örning L, Norin E, Gustaffson B, Hammarström S (1986) In vivo metabolism of leukotriene C4 in germ-free and conventional rats. Fecal excretion of N-acetyl-leukotriene E4. J Biol Chem 261:766–771
Örning L, Krivi G, Bild G, Gierse J, Aykent S, Fitzpatrick FA (1991a) Inhibition of leukotriene A4 hydrolase/aminopeptidase by captopril. J Biol Chem 266:16507–16511
Örning L, Krivi G, Fitzpatrick FA (1991b) Leukotriene A4 hydrolase. Inhibition by bestatin and intrinsic aminopeptidase activity establish its functional resemblance to metallohydrolase enzymes. J Biol Chem 266:1375–1378
Ormstad K, Uehara N, Orrenius S, Örning L, Hammarström S (1982) Uptake and metabolism of leukotriene C4 by isolated rat organs and cells. Biochem Biophys Res Commun 104:1434–1440
Osmundsen H, Bremer J, Pedersen JI (1991) Metabolic aspects of peroxisomal β-oxidation. Biochim Biophys Acta 1085:141–158
Peppelenbosch MP, Tertoolen LGJ, Den Hertog J, De Laat SW (1992) Epidermal growth factor activates calcium channels by phospholipase A2/5-lipoxygenase-mediated leukotriene C4 production. Cell 69:295–303
Piper PJ (1984) Formation and actions of leukotrienes. Physiol Rev 64:744–761
Piper PJ, Krell RD (eds) (1991) Advances in the understanding and treatment of asthma. Ann NY Acad Sciences 629:89–167
Piper PJ, Conroy DM, Costello JF, Evans JM, Green CP, Price JF, Sampson AP, Spencer DA (1991) Leukotrienes and inflammatory lung disease. Ann NY Acad Sciences 629:112–119
Powell WS (1984) Properties of leukotriene B4 hydrolase from polymorphonuclear leukocytes. J Biol Chem 259:3082–3089
Reid GK, Kargman S, Vickers PJ, Mancini JA, Léveillé C, Ethier D, Miller DK, Gillard JW, Dixon RAW, Evans JF (1990) Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis. J Biol Chem 265:19818–19823
Robinson DR, Skoskiewicz M, Bloch JK, Castorena G, Hayes E, Lowenstein E, Melvin C, Michelassi F, Zapol WM (1986) Cyclooxygenase blockade elevates leukotriene E4 production during acute anaphylaxis in sheep. J Exp Med 163:1509–1517
Rokach J (ed) (1989) Leukotrienes and lipoxygenases. Chemical, biological and clinical aspects. Elsevier, Amsterdam
Rola-Pleszczynski M (1989) Leukotrienes and the immune system. J Lipid Mediators 1:149–159
Rouzer CA, Kargman S (1988) Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. J Biol Chem 263:10980–10988
Rouzer CA, Rands E, Kargman S, Jones RE, Register RB, Dixon RAF (1988) Characterization of cloned human leukocyte 5-lipoxygenase expressed in mammalian cells. J Biol Chem 263:10135–10140
Rouzer CA, Ford-Hutchinson AW, Morton HE, Gillard JW (1990) MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. J Biol Chem 265:1436–1442
Samhoun MN, Conroy RM, Piper PJ (1989) Pharmacological profile of leukotriene E4, N-acetyl E4 and four of their novel ω-and β-oxidative metabolites in airways of guineapig and man in vitro. Br J Pharmacol 98:1406–1412
Samuelsson B (1983) Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220:568–575
Samuelsson B, Funk CD (1989) Enzymes involved in the biosynthesis of leukotriene B4. J Biol Chem 264:19469–19472
Samuelsson B, Borgeat P, Hammarström S, Murphy RC (1979) Introduction of a nomenclature: leukotrienes. Prostaglandins 17:785–787
Samuelsson B, Dahlén S-E, Lindgren Jă, Rouzer CA, Serhan CN (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237:1171–1176
Saussy DL Jr, Sarau HM, Mong S, Crooke ST (1989) Mechanisms of leukotriene E4 partial agonist activity at leukotriene D4 receptors in differentiated U-937 cells. J Biol Chem 264:19845–19855
Schaub T, Ishikawa T, Keppler D (1991) ATP-dependent leukotriene export from mastocytoma cells. FEBS Lett 279:83–86
Serafin WE, Oates JA, Hubbard WC (1984) Metabolism of leukotriene B4 in the monkey. Identification of the principal nonvolatile metabolite in the urine. Prostaglandins 27:899–911
Shaw A, Krell RD (1991) Peptide leukotrienes: current status of research. J Medicinal Chem 34:1235–1242
Shirley MA, Murphy RC (1990) Metabolism of leukotriene B4 in isolated rat hepatocytes. Involvement of 2,4-dienoyl-coenzyme A reductase in leukotriene B4 metabolism. J Biol Chem 265:16288–16295
Shirley MA, Reidhead CT, Murphy RC (1992) Chemotactic LTB4 metabolites produced by hepatocytes in the presence of ethanol. Biochem Biophys Res Commun 185:604–610
Snyder DW, Fleisch JK (1989) Leukotriene receptor antagonists as potential therapeutic agents. Annu Rev Pharmacol Toxicol 29:123–143
Soberman RJ, Sutyak JP, Okita RT, Wendelborn DF, Roberts II LJ, Austen KF (1988) The identification and formation of 20-aldehyde leukotriene B4. J Biol Chem 263:7996–8002
Söderström M, Hammarström S, Mannervik B (1988) Leukotriene C synthase in murine mastocytoma cells: a novel enzyme distinct from cystolic and microsomal glutathione transferase. Biochem J 250:713–718
Sola A, Voelkel N, Maclouf J, Murphy RC (1990) Leukotriene E4 elimination and metabolism in normal human subjects. J Biol Chem 265:21771–21778
Speeg KV, Maldonado AL, Liaci J, Muirhead D (1992) Effect of cyclosporine on colchicine secretion by a liver canalicular transporter studied in vivo. Hepatology 15:899–903
Stene DO, Murphy RC (1988) Metabolism of leukotriene E4 in isolated rat hepatocytes. Identification of β-oxidation products of sulfidopeptide leukotrienes. J Biol Chem 263:2773–2778
Sumimoto H, Kusunose E, Gotoh Y, Kusunose M, Minakami S (1990) Leukotriene B4 ω-hydroxylase in rat liver microsomes: identification as a cytochrome P-450 that catalyzes prostaglandin A1 ω-hydroxylation, and participation of cytochrome b5. J Biochem 108:215–221
Tagari P, Ethier D, Carry M, Korley V, Charleson S, Girard Y, Zamboni R (1989) Measurement of urinary leukotrienes by reversed-phase liquid chromatography and radio-immunoassay. Clin Chem 35:388–391
Tagari P, Rasmussen JB, Delorme D, Girard Y, Eriksson L-O, Charleson S, Ford-Hutchinson AW (1990) Comparison of urinary leukotriene E4 and 16-carboxytetranordihydro leukotriene E4 excretion in allergic asthmatics after inhaled antigen. Eicosanoids 3:75–80
Tateson JE, Randall RW, Reynolds CH, Jackson WP, Bhattacherjee P, Salmon JA, Garland LG (1988) Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. Br J Pharmacol 94:528–539
Taylor GW, Taylor I, Black P, Maltby NH, Fuller RW, Dollery CT (1989) Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet i:584–589
Uehara N, Ormstad K, Örning L, Hammarström S (1983) Characteristics of the uptake of cysteine-containing leukotrienes by isolated hepatocytes. Biochim Biophys Acta 732:69–74
Verhagen J, Bruynzeel PLB, Koedam JA, Wassink GA, de Boer M, Terpstra GK, Kreukniet J, Veldink GA, Vliegenthart JFG (1984) Specific leukotriene formation by purified human eosinophils and neutrophils. FEBS Lett 168:23–28
Weckbecker G, Keppler D (1986) Leukotriene C4 metabolism by hepatoma cells deficient in the uptake of cysteinyl leukotrienes. Eur J Biochem 154:559–562
Westcott JY, Thomas RB, Voelkel NF (1991) Elevated urinary leukotriene E4 in patients with ARDS and severe burns. Prostaglandins Leukotrienes and Essential Fatty Acids 43:151–158
Wettstein M, Gerok W, Häussinger D (1989) Metabolism of cysteinyl leukotrienes in non-recirculating rat liver perfusion. Eur J Biochem 181:115–124
Yoshimoto T, Soberman RJ, Spur B, Austen KF (1988) Properties of highly purified leukotriene C4 synthase of guinea pig lung. J Clin Invest 81:866–871
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag
About this chapter
Cite this chapter
Keppler, D. (1992). Leukotrienes: Biosynthesis, transport, inactivation, and analysis. In: Reviews of Physiology, Biochemistry and Pharmacology, Volume 121. Reviews of Physiology, Biochemistry and Pharmacology, vol 121. Springer, Berlin, Heidelberg. https://doi.org/10.1007/BFb0033192
Download citation
DOI: https://doi.org/10.1007/BFb0033192
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-55969-6
Online ISBN: 978-3-540-47334-3
eBook Packages: Springer Book Archive